If you've developed a novel chemical compound, polymer, drug formulation, or engineered material, a composition of matter patent may be your strongest form of intellectual property protection. Unlike a patent on a process or a machine, a composition of matter patent protects the substance itself — its structure, its properties, and in many cases all of its uses, regardless of how it is made.
This guide explains exactly what these patents cover, how the USPTO evaluates them, what the landmark cases mean for inventors today, and how the application process works — written by a practicing patent attorney with a formal background in chemistry.
Table of Contents
- What Is a Composition of Matter Patent?
- Chemical Union vs. Mechanical Mixture: The Core Distinction
- Composition of Matter vs. Utility Patent: What's the Difference?
- USPTO Requirements: Novelty, Non-Obviousness & Utility
- Real-World Examples Across Industries
- What Cannot Be Patented as a Composition of Matter
- The Application Process: Claims, Prior Art & Examination
- Costs and Timeline
- How Patent Law in Biotechnology Has Evolved
- Frequently Asked Questions
1. What Is a Composition of Matter Patent?
A composition of matter patent is a form of utility patent under 35 U.S.C. § 101 that protects novel chemical compounds, mixtures, or combinations of two or more substances that interact at a molecular or atomic level. Unlike a patent on a machine or a manufacturing process, a composition of matter patent grants legal rights over the substance itself — its chemical structure, its properties, and in many cases the unique results it produces.
These patents are particularly powerful because they can prevent competitors from making, using, selling, or importing the protected compound — regardless of how it is made or what process is used. A single strong composition patent can protect a discovery across an entire industry sector.
Under U.S. patent law, the four statutory categories of patentable subject matter are: processes, machines, manufactures, and compositions of matter. Composition of matter patents fall into the last category and are most commonly sought by chemists, pharmaceutical researchers, materials scientists, and biotechnology companies. For a broader overview of all patent types, see our guide to types of patents.
2. Chemical Union vs. Mechanical Mixture: The Core Distinction
One of the most important threshold concepts in composition of matter law is the difference between a chemical union and a mechanical mixture. This distinction determines whether your combination of substances qualifies for this type of patent.
Chemical Union
A chemical union occurs when two or more substances combine and undergo a molecular-level interaction to form an entirely new substance with distinct properties. The resulting compound is not simply the sum of its parts — it has its own chemical identity, structure, and behavior.
Example: When sodium reacts with water, the result is sodium hydroxide — a new compound with completely different properties than either starting substance. That new compound could be the subject of a composition of matter patent if it were novel and useful.
Mechanical Mixture
A mechanical mixture occurs when substances are combined but retain their individual properties and do not interact at a molecular level. There is no chemical change — the components are simply co-present.
Example: A garden salad — lettuce, tomatoes, and cucumbers in a bowl. The vegetables remain chemically unchanged. This type of combination does not meet the definition of a composition of matter.
The USPTO examines whether your claimed composition represents a true chemical union. If the combination is merely mechanical, it will not qualify for a composition of matter patent — though it may still qualify for other forms of IP protection, such as a process patent or design patent.
3. Composition of Matter vs. Utility Patent: What's the Difference?
This is one of the most frequently asked questions — and the answer requires an important clarification: a composition of matter patent IS a type of utility patent. They are not two separate categories.
A utility patent is the broad umbrella. Under that umbrella, the USPTO recognizes several categories of inventions — one of which is compositions of matter. When you file for a composition of matter patent, you are filing a utility patent application and specifying the type of invention you're claiming.
| Feature | Composition of Matter Patent | Other Utility Patents |
|---|---|---|
| What it protects | A specific substance or compound | Processes, machines, manufactures |
| Coverage breadth | Can cover all uses of the compound | Tied to the specific process or device |
| Common industries | Pharma, biotech, materials science | Engineering, software, manufacturing |
| Patent term | 20 years from filing date | 20 years from filing date |
| Filing type | Utility patent application (USPTO) | Utility patent application (USPTO) |
4. USPTO Requirements: Novelty, Non-Obviousness & Utility
To receive a composition of matter patent, your invention must satisfy three core legal requirements. These apply to all utility patents, but their application to chemical compositions carries important nuance.
Novelty (35 U.S.C. § 102)
Your composition must not have been previously known, used, patented, or described in a printed publication anywhere in the world before your filing date. This is checked against prior art — the entire body of existing knowledge in the relevant field, including published scientific literature, previous patents, and conference papers.
Critical practical implication: If your compound has been described in a journal article — even your own — before you file, it may lose its novelty in most countries. Always consult a patent attorney before publishing research on a new compound. The U.S. provides a one-year grace period after your own disclosure; some other countries do not.
Non-Obviousness (35 U.S.C. § 103)
Even if your compound is novel, it must not have been obvious to a person of ordinary skill in the relevant field at the time of the invention. For chemical compositions, the examiner considers: whether there was a motivation to combine known elements, whether the resulting compound was predictable, and whether there are unexpected results or superior properties compared to prior art compounds.
Demonstrating unexpected results is one of the most powerful tools for overcoming non-obviousness rejections in chemical patent prosecution — and one of the areas where an attorney with a chemistry background can make a significant difference in how the argument is framed.
Utility (35 U.S.C. § 101)
Your composition must have a specific, credible, and substantial utility — a real-world use. In the pharmaceutical context, this often means demonstrating at least preliminary evidence of therapeutic activity. Abstract or speculative utility is not sufficient.
For biotechnology and chemical compounds, the utility requirement intersects heavily with patent eligibility questions raised by Mayo Collaborative Services v. Prometheus Laboratories (2012) and Association for Molecular Pathology v. Myriad Genetics (2013) — both covered in Section 9.
5. Real-World Examples Across Industries
Composition of matter patents are not limited to pharmaceuticals, though that industry makes the most prominent use of them.
Pharmaceuticals & Drug Development
- A novel active pharmaceutical ingredient (API) with a defined chemical structure
- A new salt or polymorph of an existing drug with improved bioavailability
- A drug-polymer conjugate that enables targeted delivery to cancer cells
- A prodrug that converts to an active therapeutic form within the body
Biotechnology & Life Sciences
- An engineered protein or antibody with a specific amino acid sequence
- A synthetic nucleotide or oligonucleotide (note: naturally occurring DNA sequences are not patentable after Myriad Genetics)
- A novel cell line or genetically modified organism
- A biosimilar with distinct structural modifications from the reference biologic
For more on biotech patent considerations, see our patent law in biotechnology guide.
Materials Science & Engineering
- A new alloy with a specific elemental composition and improved mechanical properties
- A polymer blend with a unique ratio of components producing fire-resistant characteristics
- A nanocomposite material with a specific structure enabling superior conductivity
- A biodegradable plastic compound engineered for improved environmental decomposition
Food Science & Agrochemicals
- A novel pesticide compound with a defined molecular structure
- A food preservative formulation where chemical interactions produce a new compound
- A flavor compound synthesized through a novel chemical process
6. What Cannot Be Patented as a Composition of Matter
Just as important as knowing what qualifies is understanding what does not. Several categories are explicitly excluded from patent protection, primarily due to Supreme Court decisions interpreting 35 U.S.C. § 101.
Naturally Occurring Substances
Products of nature — substances that exist in the natural world and have not been sufficiently transformed — are not patentable. In Association for Molecular Pathology v. Myriad Genetics (2013), the Supreme Court held that naturally occurring genomic DNA sequences cannot be patented, even when isolated from the body. However, the Court preserved patentability for cDNA — synthetically created DNA that does not occur naturally — when it is meaningfully different from naturally occurring sequences.
The key test is whether the claimed composition is "markedly different" from anything found in nature. A purified or isolated version of a natural substance, without more, is generally not patentable.
Abstract Matter & Natural Phenomena
Natural laws, abstract ideas, and physical phenomena cannot be patented. A claim that simply recites a natural phenomenon — even in a chemical context — will be rejected under the Mayo/Alice framework.
Mechanical Mixtures Without a Chemical Union
As discussed in Section 2, a combination of substances that simply coexist without molecular interaction does not form a patentable composition of matter.
If your invention falls into one of these excluded categories, protection may still be available through a process patent covering how you make the compound, a formulation patent on a specific drug product, or a method-of-treatment patent. A consultation with Michael Meyer can identify the strongest available path for your specific compound.
7. The Application Process: Claims, Prior Art & Examination
Filing a composition of matter patent requires a carefully prepared utility patent application with the USPTO. Here is what the process looks like in practice.
Step 1: Patent Claims Drafting
The claims are the legal heart of your patent — they define exactly what is protected. For a composition of matter, your independent claims will typically recite the chemical structure of the compound (often using Markush structures to cover a family of related compounds), the essential elements, functional groups, or structural features that define the composition, and dependent claims narrowing the composition by specific substituents, ratios, or properties.
Well-drafted claims balance breadth (covering as much as possible) against validity (being defensible against prior art). This is one of the most technically demanding aspects of patent prosecution and is where an attorney's chemistry background matters most.
Step 2: Prior Art Search & Patentability Analysis
Before or shortly after filing, a thorough prior art search is conducted across USPTO databases, international patent databases (EPO, WIPO), and scientific literature. The goal is to identify anything that could anticipate your claims or render them obvious — and to draft around it where possible.
Step 3: Filing — Provisional vs. Non-Provisional
Many applicants begin with a provisional patent application, which establishes an early priority date without the formality of full claims. You then have 12 months to file the full non-provisional application. This is particularly common in pharmaceutical and biotech research where discoveries happen quickly and additional experimental data is still being gathered. See our guide to how long a patent application takes for full timeline detail.
Step 4: USPTO Examination
A USPTO examiner with relevant technical training reviews the application and will typically issue an office action with rejections or objections. Common rejections for composition of matter patents include:
- 35 U.S.C. § 102 (anticipation) — an existing compound in the prior art reads on your claims
- 35 U.S.C. § 103 (obviousness) — your compound is a predictable modification of a known compound
- 35 U.S.C. § 101 (patent eligibility) — the compound is alleged to be a product of nature
- 35 U.S.C. § 112 (enablement/written description) — the specification does not sufficiently describe how to make and use the compound
Step 5: Prosecution & Allowance
After receiving office actions, your attorney responds with arguments and/or claim amendments. This back-and-forth process is called patent prosecution. On average, chemical and pharmaceutical patents require two to three rounds of examination before reaching allowance or appeal.
8. Costs and Timeline
These are general estimates based on common industry ranges. Costs vary based on complexity, number of claims, and the level of prosecution required. For a detailed breakdown of all patent costs, see our complete patent cost guide. Contact Michael Meyer for a specific assessment of your invention.
| Stage | Typical Cost Range | Typical Timeline |
|---|---|---|
| Provisional patent application | $1,500 – $4,000 | 1–2 months to prepare and file |
| Non-provisional utility application | $4,000 – $10,000+ | 1–3 months to prepare and file |
| USPTO examination & prosecution | $2,000 – $5,000 per office action | 1–3 years total |
| Total (typical chemical/pharma patent) | $10,000 – $50,000+ | 2–4 years to grant |
The USPTO currently takes approximately 18–24 months from filing to first office action for chemical patents. Total pendency from filing to grant averages around 20–28 months, though complex biotech applications can take longer.
9. How Patent Law in Biotechnology Has Evolved
The landscape of composition of matter patents in biotechnology has been significantly reshaped by a series of Supreme Court decisions. Understanding these developments is essential for anyone in the life sciences considering patent protection.
Association for Molecular Pathology v. Myriad Genetics (2013)
In this landmark case, the Supreme Court held that naturally occurring genomic DNA sequences are not patentable, even when isolated from the body. This eliminated broad patent claims held by Myriad Genetics on BRCA1 and BRCA2 gene sequences — patents that had effectively prevented other labs from offering genetic testing services.
However, the Court preserved patentability for cDNA — synthetically created DNA not found in nature — when meaningfully different from naturally occurring sequences.
Practical impact: Researchers working with genetic material must demonstrate that their compositions are sufficiently engineered to constitute something markedly different from what exists in nature.
Mayo Collaborative Services v. Prometheus Laboratories (2012)
The Mayo decision established a two-step framework (used in conjunction with Alice) for evaluating whether claims are directed to patent-ineligible subject matter such as natural laws. Claims that simply apply a natural phenomenon — even with additional steps — may be unpatentable if those steps are "well-understood, routine, and conventional."
For composition of matter patents, this matters most in pharmaceutical and diagnostic contexts where the claimed composition's utility depends on a natural biological mechanism.
International Considerations
Patent eligibility for compositions of matter varies significantly by jurisdiction. The European Patent Office (EPO) applies its own standards under the European Patent Convention, which differ from U.S. law — particularly around biotechnology, stem cells, and naturally derived compounds. Companies seeking global protection must evaluate each jurisdiction independently.
10. Frequently Asked Questions
What is the difference between a composition of matter patent and a product patent?
They are effectively the same thing. "Product patent" is an informal term used in some industries — particularly pharmaceuticals — to describe a patent that covers a substance itself, as opposed to the process used to make it. Composition of matter patents are the formal legal category under U.S. patent law that encompasses these protections.
Can I patent a naturally occurring compound I discovered?
Generally, no — if the compound exists in nature in the same form, it is not patentable even if you were the first to isolate it. However, if you have modified, synthesized, or combined it in a way that creates something meaningfully different from the natural version, that new form may qualify. This is a nuanced area of law and the answer depends heavily on the specific compound and how the claims are written. Consulting a patent attorney before publishing or disclosing your compound is the critical first step.
Is a pharmaceutical drug always protected by a composition of matter patent?
Not always, but composition of matter patents are the gold standard for pharmaceutical protection because they cover the compound itself regardless of its use or how it's made. In practice, a drug's full IP protection often includes several patent types: a composition patent on the active ingredient, a formulation patent on the drug product, a method-of-treatment patent on its therapeutic use, and sometimes a process patent. Together, these create layered protection commonly called a "patent thicket."
What happens when a composition of matter patent expires?
Once the patent expires — typically 20 years from the filing date — the compound enters the public domain and anyone may make, use, or sell it. In the pharmaceutical industry, this typically triggers the entry of generic drug manufacturers. This is why pharmaceutical companies often seek additional patents on formulations, dosing methods, or new indications — a practice sometimes called "evergreening."
Do I need a patent attorney to file a composition of matter patent?
While inventors can technically file patent applications as "pro se" applicants, composition of matter patents are among the most technically demanding applications to draft and prosecute. The chemical claim language must be precise, the structure-activity relationships must be clearly disclosed, and the prior art landscape in chemistry is extremely dense. An attorney with both a legal background and chemistry training is particularly well-positioned to protect your invention effectively — which is exactly the combination Michael Meyer brings to every engagement. For more on the difference between attorneys and agents, see our patent attorney vs. patent agent guide.
How long does a composition of matter patent last?
A granted U.S. composition of matter patent lasts 20 years from the earliest effective non-provisional filing date, subject to payment of maintenance fees at 3.5, 7.5, and 11.5 years after grant. Pharmaceutical patents may also be eligible for Patent Term Extension (PTE) under the Hatch-Waxman Act to compensate for time spent in FDA regulatory review — potentially adding up to 5 additional years of exclusivity.
What is the best first step to protect a new compound I've developed?
The most important first step is to consult a patent attorney before disclosing your compound publicly — including in publications, conference presentations, or grant applications. The U.S. provides a one-year grace period after your own disclosure, but most other countries require absolute novelty with no prior disclosure at all. Early consultation allows you to file a provisional patent application quickly, lock in your priority date, and then develop the full application with comprehensive claims.
Not Sure If Your Compound Qualifies for a Composition of Matter Patent?
Michael Meyer is a USPTO-registered patent attorney with a chemistry degree from the University of Nebraska at Omaha and a J.D. from Creighton University — uniquely positioned to evaluate chemical, pharmaceutical, and materials science inventions and advise on the strongest path to protection.
Schedule a consultation — or call 402-321-7532.
Warning & Disclaimer: The pages, articles, and comments on michaelmeyerlaw.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinions and views of the author as of the time of publication. For advice specific to your situation, please contact a licensed attorney.